Ledger.Open graph →

SEC Form D · filed August 11, 2022

AEON Biopharma, Inc

Offering

$30.0M

Sold

$30.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

IRVINE, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Chris Carr · Irvine, CAExec Vikram Malik · Irvine, CADirector Simone Blank · Irvine, CADirector Richard Taketa · Irvine, CADirector Darren O'Brien · Irvine, CADirector Jost Fischer · Irvine, CADirector Chad Oh · Irvine, CAExec Robert Grant · Irvine, CADirector Marc Forth · Irvine, CAExec Alex Wilson · Irvine, CAExec Jessica Lee · Boston, MADirector Marc Feliciano · Boston, MADirector Rockstep Fund I Management LLC · Houston, TXDirector Spencer R. Powers · Chicago, ILExec Beth M. Cranis · Austin, TXExec Aidan Kehoe · New York, NYExec L.L.C. TMG Parkside GP · Bethesda, MDExec Erik Gustafson · Boston, MADirector Marie Claire Hickey · San Mateo, CADirector Cody Shandraw · Jupiter, FLDirector Jeremy D. Boughton · Pittsburgh, PADirector Ed Boyle · Houston, TXDirector Sean Churchill · Houston, TXDirector Sarah Farrell · San Francisco, CADirector John Dickinson · San Francisco, CAExec Robert Frisbie, Jr · Palm Beach, FLExec Cody Crowell · Palm Beach, FLDirector Angelo A. Rufino · New York, NYDirector Anil Hingorani · Mountain Lakes, NJExec Brian Shin · Reno, NVExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗